Zevenbergen Capital Investments LLC lessened its holdings in Xometry, Inc. (NASDAQ:XMTR – Free Report) by 12.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 9,750 shares of the company’s stock after selling 1,350 shares during the period. Zevenbergen Capital Investments LLC’s holdings in Xometry were worth $416,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also modified their holdings of XMTR. Connor Clark & Lunn Investment Management Ltd. acquired a new stake in shares of Xometry during the third quarter valued at about $355,000. Intech Investment Management LLC acquired a new stake in Xometry in the third quarter valued at approximately $205,000. Charles Schwab Investment Management Inc. grew its holdings in Xometry by 4.8% during the 3rd quarter. Charles Schwab Investment Management Inc. now owns 354,849 shares of the company’s stock worth $6,519,000 after acquiring an additional 16,396 shares in the last quarter. FMR LLC increased its position in shares of Xometry by 40.2% in the 3rd quarter. FMR LLC now owns 4,078,462 shares of the company’s stock valued at $74,921,000 after purchasing an additional 1,169,778 shares during the last quarter. Finally, Verition Fund Management LLC acquired a new stake in Xometry in the third quarter valued at $383,000. 97.31% of the stock is currently owned by hedge funds and other institutional investors.
Xometry Stock Performance
NASDAQ XMTR opened at $25.72 on Monday. The stock has a market cap of $1.29 billion, a price-to-earnings ratio of -24.50 and a beta of 0.69. The business has a fifty day moving average of $31.23 and a 200-day moving average of $28.83. Xometry, Inc. has a fifty-two week low of $11.08 and a fifty-two week high of $45.33. The company has a quick ratio of 4.55, a current ratio of 4.59 and a debt-to-equity ratio of 0.90.
Insiders Place Their Bets
Wall Street Analysts Forecast Growth
A number of analysts have recently commented on the company. JPMorgan Chase & Co. upgraded Xometry from a “neutral” rating to an “overweight” rating and lifted their target price for the stock from $25.00 to $45.00 in a research report on Wednesday, December 18th. Citigroup decreased their price target on Xometry from $46.00 to $39.00 and set a “buy” rating for the company in a report on Thursday, February 27th. JMP Securities reaffirmed a “market outperform” rating and issued a $42.00 target price on shares of Xometry in a report on Monday, February 10th. Wedbush reissued an “outperform” rating and set a $48.00 target price on shares of Xometry in a research note on Friday, December 20th. Finally, Cantor Fitzgerald raised their target price on Xometry from $12.00 to $20.00 and gave the company an “underweight” rating in a report on Wednesday, February 26th. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $36.11.
Check Out Our Latest Stock Report on XMTR
Xometry Company Profile
Xometry, Inc operates an online marketplace that enables buyers to source custom-manufactured parts and assemblies in the United States and internationally. It provides computer numerical control manufacturing, sheet metal forming, and sheet cutting; 3D printing, including fused deposition modeling, direct metal laser sintering, PolyJet, stereolithography, selective laser sintering, binder jetting, carbon digital light synthesis, multi jet fusion, and lubricant sublayer photo-curing; and die casting, stamping, injection molding, urethane casting, tube cutting, and tube bending, as well as finishing services, rapid prototyping, and high-volume production services.
Recommended Stories
- Five stocks we like better than Xometry
- 3 Warren Buffett Stocks to Buy Now
- Rising E-Commerce Sales May Spark a Stock Breakout—What to Buy
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Chinese Fintech FinVolution: Buy, Sell, or Hold?
- Quiet Period Expirations Explained
- AbbVie Stock Boosts Portfolios With Entry Into Weight Loss Market
Receive News & Ratings for Xometry Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xometry and related companies with MarketBeat.com's FREE daily email newsletter.